Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02276534 · ClinicalTrials.gov registry record · NA

SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)

A NA study of Autism Spectrum Disorder, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT02276534 is a NA study of Autism Spectrum Disorder that has completed, run by Vanderbilt University. The registered enrollment target is 136 participants, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02276534, a NA study of Autism Spectrum Disorder, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The investigator's goal is to address the need for the development of social interventions for youth with autism in an innovative intervention, SENSE Theatre. The intervention blends established behavioral strategies with theatre techniques that emphasize the involvement of peers, play and performance. The resulting synergy extends promising pilot studies in a randomized group experiment.

Conditions Studied

Interventions

  • BEHAVIORAL Delayed Intervention
  • BEHAVIORAL SENSE Theatre

Study Locations (1)

Tennessee

  • Vanderbilt Kennedy Center - Nashville

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2014-08
Est. Completion 2017-05
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT02276534

The ClinicalTrials.gov registry entry for NCT02276534 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Delayed Intervention is the first listed.

NCT02276534 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02276534 about?

NCT02276534 is a clinical study titled "SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)". The investigator's goal is to address the need for the development of social interventions for youth with autism in an innovative intervention, SENSE Theatre. The intervention blends established behavioral strategies with theatre techniques that emphasize the involvement of peers, play and performan...

What is the current status of trial NCT02276534?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2014-08. Estimated completion is 2017-05.

What conditions does trial NCT02276534 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT02276534?

The interventions under investigation include: Delayed Intervention (BEHAVIORAL), SENSE Theatre (BEHAVIORAL).

Who is sponsoring clinical trial NCT02276534?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02276534 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.